Open Heart

MARCH 23, 2023

Background Hypertension is a silent killer that causes serious health issues in all parts of the world. It is risk factor for cardiovascular disease, stroke and kidney disease. Self-monitoring practice has been identified as an important component of hypertension management. and then exported to SPSS V.25

Blood Pressure 40

Blood Pressure Hypertension Hospital Kidney Disease 40

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Circulation

NOVEMBER 11, 2024

Evaluate the benefit in important cardiovascular outcomes and safety in elderly patients of a blood pressure control ≤ 130mmHg compared to standard of care.Methods:The research was performed in PubMed, EMBASE, Scielo, LILACS, and Cochrane Central Register of Controlled Trials (CENTRAL) from January 1st, 2013 to May 1st, 2023.

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Dr. Malcolm Kendrick

DECEMBER 8, 2023

Here, for example, plucked at random, is a reference to the latest NICE guidelines on the management of hypertension (high blood pressure) in adults. But this, the primary guideline on hypertension for adults, is but one of many. There are associated guidelines on hypertension in pregnancy. 2 Have I read the entire document.

Blood Pressure 90

Blood Pressure Blog Document Hypertension 90

Circulation

NOVEMBER 11, 2024

Background:Dietary magnesium (Mg+2) deficiency has been linked to hypertension, chronic kidney disease, and cardiovascular disease. Circulation, Volume 150, Issue Suppl_1 , Page A4143897-A4143897, November 12, 2024. High sodium intake and reduced dietary Mg+2consumption are associated with elevated blood pressure.

Blood Pressure 40

Blood Pressure Inpatient Kidney Disease Hypertension 40

Cardiometabolic Health Congress

JULY 12, 2023

Through CMHC’s Cardiometabolic Education Hubs , learners can easily access an array of education related to 12 therapeutic or practice topics: Cardiovascular Disease Care Delivery Implementation Chronic Kidney Disease Clinical Array Diabetes Management Diversity, Equity, and Inclusion Hypertension Interventional Cardiology Lifestyle Management (..)

Education 40

Education Webinar CME Pediatrics 40

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8%

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Background:Racial disparities have been well described in cardiovascular disease. Primary outcome was ischemic stroke, while secondary outcomes were all-cause mortality, heart failure, cardiogenic shock, MACE (composite of all-cause mortality, heart failure, and ischemic stroke), and acute kidney injury (AKI).Result:After

Cardiogenic Shock 40

Cardiogenic Shock Stroke Strokes Outcomes 40

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD). 4 Approximately 6.7 million adults in the U.S. NCT06033950.

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

DAIC

JUNE 28, 2024

milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.

Kidney Disease 111

Kidney Disease Blood Pressure Cardiovascular Disease Hypertension 111

CardiacWire

OCTOBER 27, 2024

It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. Hypertension Problems: Another JAMA study highlighted the U.S.’s

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

Cardiometabolic Health Congress

JULY 10, 2024

Bakris , an internationally recognized and influential nephrologist and hypertension expert, who passed away on June 15, 2024, at the age of 72. Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovascular diseases and related conditions. New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] 5, 6] So, it seems that once cardiovascular disease is present, then obesity may offer some degree of protection.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Stroke Journal

JANUARY 30, 2025

Objective:High calcium (Ca), low phosphate(P), and Ca-P product (CPP) levels are associated with cardiovascular disease and coronary artery atherosclerosis in patients with chronic kidney disease. Stroke, Volume 56, Issue Suppl_1 , Page AWP184-AWP184, February 1, 2025.

Plaque 40

Plaque Atherosclerosis Kidney Disease Hypertension 40

Physiologically Speaking

DECEMBER 15, 2023

But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovascular diseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovascular diseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Cardiometabolic Health Congress

JUNE 29, 2023

“As a women’s cardiovascular health leader specializing in lipidology, I know firsthand that women’s cardiovascular and cardiometabolic care must be approached with unique tools and strategies.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Education Webinar Kidney Disease 40

Cardiometabolic Health Congress

DECEMBER 7, 2023

Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD).

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2024

BackgroundCardiovascular disease(CVD) remains a significant global challenge. Asthma, which is characterized by airway hyperresponsiveness and reversible and limited airflow, plays an important role in cardiovascular diseases.

Cardiovascular Disease 52

Cardiovascular Disease Heart Failure Angina BMI 52

Cardiometabolic Health Congress

DECEMBER 17, 2024

Regular assessment of eGFR and UACR, particularly in high-risk populations such as those with diabetes or hypertension, provides crucial insights into patient health. Even small decreases in eGFRless than 60 mL/min/1.73mare associated with an increased cardiovascular risk.

Kidney Disease 52

Kidney Disease CME Research Education 52

Frontiers in Cardiovascular Medicine

DECEMBER 11, 2024

The younger the age of onset of hypertension is, the greater the risk of cardiovascular disease (CVD) and cardiovascular death. Group 1, no hypertension (n=19,516); Group 2, age of onset <35 years (n=2,180); Group 3, 35 age of onset <45 years (n=2,128); and Group 4, age of onset 45 years (n=6,789).

Kidney Disease 52

Kidney Disease Hypertension Cardiovascular Disease Research 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Moreover, cardiovascular disease in women continues to be underrepresented and undertreated.

CME 103

CME Obesity Heart Failure Biomarkers 103